Latest News & Updates
Breaking News
8 hours ago
Simantini Singh Deo
Other trending news you may like to read
OMass Therapeutics Signs Exclusive Collaboration And License Deal With Genentech To Develop & Commercialize New Therapies For Inflammatory Bowel Disease
OMass partners with Genentech in $420M+ deal to advance preclinical small molecule therapy for inflammatory bowel disease.
Simantini Singh Deo
ELMACH Highlights EPI-3015 PDA Blister Machine for High-Precision, Multi-Material Packaging
ELMACH introduces EPI-3015 PDA: compact, modular blister machine with 100% inspection and fast changeovers for regulated packaging.
Team Pharma Now
Novartis’ Leqvio® Demonstrates Statistically Significant And Clinically Meaningful Early LDL-C Goal Achievement With Lower Rates Of Muscle Pain
Novartis’ V-DIFFERENCE study shows Leqvio helps 85% of high-cholesterol patients reach LDL-C goals vs 31% on placebo.
Simantini Singh Deo
Novo Nordisk’s Wegovy® Shows 57% Greater Protection Against Heart Attack, Stroke, Or Death Versus Tirzepatide In Real-World Study Of Obese Patients With Cardiovascular Disease
Novo Nordisk’s STEER study shows Wegovy cuts cardiovascular risk by up to 57% vs tirzepatide in obesity patients.
Simantini Singh Deo
